Free
Research Article  |   September 2002
Validity of the Árnadóttir OT-ADL Neurobehavioral Evaluation (A-ONE): Performance in Activities of Daily Living and Neurobehavioral Impairments of Persons With Left and Right Hemisphere Damage
Sigrún Gardarsdóttir; Susan Kaplan
Author Affiliations
  • Sigrún Gardarsdóttir, OT, MS, is Director of Occupational Therapy, Department of Rehabilitation and Neurology, Landspítali–The National University Hospital, Reykjavík, Iceland, and is Assistant Professor, Department of Occupational Therapy, University of Akureyri, Sólborg, 600 Akureyri, Iceland. (Mailing address: Tómasarhagi 17, 107 Reykjavík, Iceland; sigrgard@landspitali.is)
  • Susan Kaplan, PhD, MBA, OTR, is Associate Professor, Occupational Therapy Department, College of Health Sciences, Florida International University, Miami, Florida
Article Information
Neurologic Conditions / Stroke / Assessment and Stroke
Research Article   |   September 2002
Validity of the Árnadóttir OT-ADL Neurobehavioral Evaluation (A-ONE): Performance in Activities of Daily Living and Neurobehavioral Impairments of Persons With Left and Right Hemisphere Damage
American Journal of Occupational Therapy, September/October 2002, Vol. 56, 499-508. doi:10.5014/ajot.56.5.499
American Journal of Occupational Therapy, September/October 2002, Vol. 56, 499-508. doi:10.5014/ajot.56.5.499
This content is PDF only. Please click on the PDF icon to access.
Abstract

OBJECTIVE. The Árnadóttir OT-ADL Neurobehavioral Evaluation (A-ONE) is a standardized assessment that links performance in activities of daily living (ADL) to neurobehavioral impairments. This study tested the construct validity of the A-ONE.

METHOD. From two hospitals in Iceland, 42 patients between 45 and 87 years of age who had sustained either a right or a left cerebrovascular accident (CVA) were evaluated on the Functional Independence Scale (FIS) and Neurobehavioral Specific Impairment Subscale (NSIS) of the A-ONE. The Mann Whitney U test and chi-square test were used to explore possible differences between the performance of participants with left and right CVA. Descriptive statistics were calculated for demographic data and for items on the FIS and NSIS. The level of significance was set at p < .05.

RESULTS. Three of 18 ADL items observed on the FIS and 13 of 46 items on the NSIS discriminated at a statistically significant level between the left and right CVA groups.

CONCLUSION. The results provide minimal support for the construct validity of the A-ONE related to differentiating between ADL performance of persons with left and right CVA. However, results regarding the ability of the A-ONE to detect and lateralize impairments agreed with literature regarding lesion sites for the impairments.